145 related articles for article (PubMed ID: 33479772)
1. Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma.
Hong JH; Kang S; Sa JK; Park G; Oh YT; Kim TH; Yin J; Kim SS; D'Angelo F; Koo H; You Y; Park S; Kwon HJ; Kim CI; Ryu H; Lin W; Park EJ; Kim YJ; Park MJ; Kim H; Kim MS; Chung S; Park CK; Park SH; Kang YH; Kim JH; Saya H; Nakano I; Gwak HS; Yoo H; Lee J; Hur EM; Shi B; Nam DH; Iavarone A; Lee SH; Park JB
Brain; 2021 Mar; 144(2):636-654. PubMed ID: 33479772
[TBL] [Abstract][Full Text] [Related]
2. Nogo receptor is involved in the adhesion of dendritic cells to myelin.
McDonald CL; Steinbach K; Kern F; Schweigreiter R; Martin R; Bandtlow CE; Reindl M
J Neuroinflammation; 2011 Sep; 8():113. PubMed ID: 21906273
[TBL] [Abstract][Full Text] [Related]
3. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
[TBL] [Abstract][Full Text] [Related]
4. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
[TBL] [Abstract][Full Text] [Related]
5. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
[TBL] [Abstract][Full Text] [Related]
6. Expression of Nogo receptor 1 in the regeneration process of the mouse olfactory epithelium.
Chen HX; Zeng XP; Sun YQ; Fu QL
Neuroreport; 2016 Jul; 27(10):717-23. PubMed ID: 27138950
[TBL] [Abstract][Full Text] [Related]
7. USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.
Lee JK; Chang N; Yoon Y; Yang H; Cho H; Kim E; Shin Y; Kang W; Oh YT; Mun GI; Joo KM; Nam DH; Lee J
Neuro Oncol; 2016 Jan; 18(1):37-47. PubMed ID: 26032834
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity.
Raiker SJ; Lee H; Baldwin KT; Duan Y; Shrager P; Giger RJ
J Neurosci; 2010 Sep; 30(37):12432-45. PubMed ID: 20844138
[TBL] [Abstract][Full Text] [Related]
9. Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.
Zhang L; Kuang X; Zhang J
J Genet Genomics; 2011 Nov; 38(11):515-23. PubMed ID: 22133682
[TBL] [Abstract][Full Text] [Related]
10. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
11. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
[TBL] [Abstract][Full Text] [Related]
12. Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
Wang X; Zhou T; Maynard GD; Terse PS; Cafferty WB; Kocsis JD; Strittmatter SM
Brain; 2020 Jun; 143(6):1697-1713. PubMed ID: 32375169
[TBL] [Abstract][Full Text] [Related]
13. Nogo receptor blockade overcomes remyelination failure after white matter stroke and stimulates functional recovery in aged mice.
Sozmen EG; Rosenzweig S; Llorente IL; DiTullio DJ; Machnicki M; Vinters HV; Havton LA; Giger RJ; Hinman JD; Carmichael ST
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8453-E8462. PubMed ID: 27956620
[TBL] [Abstract][Full Text] [Related]
14. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.
Kawakami Y; Saito Y; Nakagawa R; Kurihara Y; Takei K
Neurosci Lett; 2018 Sep; 683():61-68. PubMed ID: 29953923
[TBL] [Abstract][Full Text] [Related]
15. Myelin regulates immune cell adhesion and motility.
Pool M; Niino M; Rambaldi I; Robson K; Bar-Or A; Fournier AE
Exp Neurol; 2009 Jun; 217(2):371-7. PubMed ID: 19328785
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.
Hånell A; Clausen F; Björk M; Jansson K; Philipson O; Nilsson LN; Hillered L; Weinreb PH; Lee D; McIntosh TK; Gimbel DA; Strittmatter SM; Marklund N
J Neurotrauma; 2010 Jul; 27(7):1297-309. PubMed ID: 20486800
[TBL] [Abstract][Full Text] [Related]
17. Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage.
Ferraro GB; Morrison CJ; Overall CM; Strittmatter SM; Fournier AE
J Biol Chem; 2011 Sep; 286(36):31418-24. PubMed ID: 21768085
[TBL] [Abstract][Full Text] [Related]
18. The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease.
Yoon G; Shah SA; Ali T; Kim MO
Mol Neurobiol; 2018 Aug; 55(8):6673-6686. PubMed ID: 29335844
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
[TBL] [Abstract][Full Text] [Related]
20. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
